Trademark Overview
On Friday, October 7, 2022, a trademark application was filed for AKTERLY with the United States Patent and Trademark Office. The USPTO has given the AKTERLY trademark a serial number of 97623317. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, August 28, 2023. This trademark is owned by Kalvista Pharmaceuticals Limited. The AKTERLY trademark is filed in the Pharmaceutical Products category with the following description:
(Based on Intent to Use) Pharmaceutical preparations for the treatment of angioedema; Pharmaceutical preparations for the treatment of hereditary angioedema; Pharmaceutical preparations for the treatment of bradykinin mediated inflammatory disorders; Pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; Pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders; Pharmaceutical preparations for containing sebetralstat; Pharmaceutical preparations for containing feniralstat(Based on 44(d) Priority Application) Pharmaceutical preparations for the treatment of angioedema; Pharmaceutical preparations for the treatment of hereditary angioedema; Pharmaceutical preparations for the treatment of bradykinin mediated inflammatory disorders; Pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; Pharmaceutical preparations fo...
